Advertisement covers EACS 2013

6 Approaches to Improving Long-Term HIV Treatment Adherence

December 3, 2013


Monitoring-Based Strategies

Monitoring-Based Strategies

Reducing viral load to an undetectable level is one of the main goals of starting HIV treatment. However, the period of time that begins immediately after patient gets to undetectable is when he or she is most at risk of a viral rebound, according to study results by Viviane D. Lima, M.D., and colleagues.

This "risk phase" is shortest, at about 12 months, in patients with an adherence level of 95% or higher. At lower levels of adherence, that risk phase lengthens to between 48 and 60 months.

"Although perfect adherence remains an important goal of therapy to prevent disease progression, individuals with long-term viral suppression may be able to miss more doses without experiencing viral rebound," Lima et al write.

This article was provided by It is a part of the publication The 14th European AIDS Conference (EACS 2013).


Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.